← Leaderboards
Vanessa Jacoby
Theranova, Llc
$10,995,708
Attributed
$31,398,823
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.4M · FY2021–25$20M$15M$10M$5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,398,823 · 4
By mechanism
UL1$25,481,300 · 1
R01$3,869,794 · 2
R44$2,047,729 · 1
Top collaborators
- Daniel Rogers Burnett3 shared
- Harold R Collard3 shared
- Alison Huang3 shared
- Tung T Nguyen3 shared
- Wanda K Nicholson3 shared
- Elizabeth A Stewart3 shared
- Ganesa Rebecca Wegienka3 shared
Most similar at Theranova, Llc
Same institution · by research overlap
- Daniel Rogers Burnett$18,342,595
Others in their field
Other Emerging Leaders on “Quality Of Life”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$40,849,810
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Greg Yothers · University Of Chicago$35,003,821
Research focus
Quality Of LifeFutureWomanReportingParticipantHysterectomyProceduresSymptomsClinical ResearchHemorrhagePremenopauseHomeImpairmentFunctional DisorderFundingInfertilityEthnic DiversityClinical PracticeClinical TrialsFibroid TumorEffectivenessEnrollmentClinical DataClinical Care
Grant awards (12)
Clinical and Translational Science Institute$8,507,126
UL1 · FY2025 · TR · contact PI
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial$676,493
R01 · FY2025 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$600,362
R01 · FY2025 · HD
Clinical and Translational Science Institute$8,497,502
UL1 · FY2024 · TR · contact PI
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial$671,122
R01 · FY2024 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$592,123
R01 · FY2024 · HD
Clinical and Translational Science Institute$8,476,672
UL1 · FY2023 · TR · contact PI
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial$694,900
R01 · FY2023 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$634,794
R01 · FY2023 · HD
A Photo-based Menstrual Blood Loss Metric$608,576
R44 · FY2023 · HD
A Photo-based Menstrual Blood Loss Metric$721,899
R44 · FY2022 · HD
A Photo-based Menstrual Blood Loss Metric$717,254
R44 · FY2021 · HD